🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This phase II trial studies how well pembrolizumab and epacadostat work in ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-12-21
Trial ID
NCT03602586
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of pembro...
Status
Completed
Location
Arizona Oncology Associates PC- HOPE
Start Date
2017-12-04
Trial ID
NCT03361865
Treatments Being Tested
The KEO study is a single arm phase II trial including 44 patients with T1N...
Status
Withdrawn
Location
University of Chicago
Start Date
2018-01-22
Trial ID
NCT03325465
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of pembro...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2018-01-09
Trial ID
NCT03322566
Treatments Being Tested
This is an open-label, Phase 1/2 study in subjects with advanced or metasta...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2017-02-27
Trial ID
NCT02959437
Treatments Being Tested
The purpose of this study is to test any good and bad effects of the combin...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2018-01-23
Trial ID
NCT03414229
Treatments Being Tested
Expression of IDO and PD-1/L1 has been found to be increased in endometrial...
Status
Withdrawn
Location
Fox Chase Cancer Center
Start Date
2018-09
Trial ID
NCT03310567
Treatments Being Tested
The purpose of this study is to assess the safety and antitumor activity of...
Status
Terminated
Location
University of Alabama
Start Date
2018-03-01
Trial ID
NCT03361228
Treatments Being Tested
This phase II trial studies how well tavokinogene telseplasmid with electro...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-05-02
Trial ID
NCT03823131
Treatments Being Tested